In this study, we synthesized amodiaquine derivatives bearing H-, F-, CF3-, NO2-, CN-, CO2H or CH3O- groups on the aminoquinoline ring of AMQ to determine their ability to moderate the activity of AChE and BChE, the main targets in the symptomatic treatment of AD. Here, BCHE is linked to Alzheimer disease.